ID: ALA428469

Max Phase: Preclinical

Molecular Formula: C47H58N2O16

Molecular Weight: 906.98

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)NCC1=C2[C@@H](OC(C)=O)C(=O)[C@@]3(C)[C@H]([C@H](OC(=O)c4ccccc4)[C@](O)(C[C@@H]1OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c1ccccc1)C2(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]3O

Standard InChI:  InChI=1S/C47H58N2O16/c1-24(50)48-22-29-30(62-41(57)35(54)34(27-16-12-10-13-17-27)49-42(58)65-43(4,5)6)21-47(59)39(63-40(56)28-18-14-11-15-19-28)37-45(9,31(53)20-32-46(37,23-60-32)64-26(3)52)38(55)36(61-25(2)51)33(29)44(47,7)8/h10-19,30-32,34-37,39,53-54,59H,20-23H2,1-9H3,(H,48,50)(H,49,58)/t30-,31-,32+,34-,35+,36+,37-,39-,45+,46-,47+/m0/s1

Standard InChI Key:  UNRBLZOZSRQBLE-MIDYMNAOSA-N

Associated Targets(Human)

PC-6 212 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PC-12 7051 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

P388 20296 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 906.98Molecular Weight (Monoisotopic): 906.3786AlogP: 2.95#Rotatable Bonds: 11
Polar Surface Area: 259.62Molecular Species: NEUTRALHBA: 16HBD: 5
#RO5 Violations: 2HBA (Lipinski): 18HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.90CX Basic pKa: CX LogP: 1.79CX LogD: 1.79
Aromatic Rings: 2Heavy Atoms: 65QED Weighted: 0.12Np Likeness Score: 1.56

References

1. Uoto K, Mitsui I, Terasawa H, Soga T.  (1997)  First synthesis and cytotoxic activity of novel docetaxel analogs modified at the C18-position,  (23): [10.1016/S0960-894X(97)10128-7]

Source